@trimexplainspeps's GHK-Cu peptide claims, fact-checked

What did @trimexplainspeps actually say?

The creator made a series of practical claims about GHK-Cu: that it helps with acne, fine lines, wrinkles, and redness; that 2-5mg daily is the appropriate dose range; that a loading phase is unnecessary; and that long, unbroken cycles are preferable to the cycling protocols you often hear about online. They also walked through a specific reconstitution calculation for a 50mg vial with 3mL bacteriostatic water and gave subcutaneous injection guidance, recommending the upper glutes or "love handles" over the stomach to avoid scarring and welts.

The creator delivered this as if it were settled, practical knowledge, not as speculation. They acknowledged they personally ran GHK-Cu for a year continuously. That personal anecdote is doing a lot of work here, and it deserves scrutiny.

Does the science back this up?

Partially, but the evidence base is thinner than this video implies. GHK-Cu (copper peptide GHK-Cu) has genuinely interesting preclinical data behind it, including work by Pickart and colleagues published across multiple journals over decades. The problems start when you try to translate that data to injectable human dosing.

The skin-related benefits, particularly wound healing, collagen synthesis stimulation, and anti-inflammatory activity, have support in cell and animal studies. Pickart et al. (2015, Journal of Aging Research) reviewed evidence that GHK-Cu can modulate gene expression linked to inflammation and tissue repair. A 2018 study by Gorouhi and Maibach in the International Journal of Cosmetic Science found topical copper peptides showed measurable effects on skin laxity and fine lines. That is topical, not injectable. The leap from topical efficacy to subcutaneous injection protocols lacks direct clinical trial support in humans. The creator does not acknowledge this gap.

What did they get wrong (or right)?

The reconstitution math they provided is actually correct. If you dissolve 50mg of GHK-Cu in 3mL of bacteriostatic water, you get roughly 16.67mg per mL. From there, 2mg does equal approximately 12 units on an insulin syringe, 3mg equals 18 units, and so on. That calculation checks out, and it is the kind of practical information that is genuinely useful and often poorly explained elsewhere.

Where they went wrong: the claim that you can run GHK-Cu continuously "for as long as you can" with no structured break is presented without any pharmacological reasoning or human safety data. There are no long-term human trials on continuous subcutaneous GHK-Cu use. Copper homeostasis is a real physiological concern. Excess copper accumulation is associated with oxidative stress, and while GHK-Cu delivers copper in a chelated, biologically controlled form, asserting year-long continuous use is safe because one person did it and was "fine" is not evidence. The acne claim also lacks specific injectable GHK-Cu support in the literature.

What should you actually know?

GHK-Cu is one of the more legitimately researched peptides in the cosmetic and wound-healing space, but the research was not done on people injecting 2-5mg subcutaneously every day for a year. Most of the human-applicable data involves topical formulations or in vitro models. The injectable market exists largely outside clinical trial infrastructure.

The injection site advice, rotating between upper glutes and love handles to minimize scar tissue formation, is reasonable harm reduction guidance for anyone already using subcutaneous injections, but it is not a medical recommendation and should not be treated as one. The creator also directs viewers to "a source" in their bio, which implies purchasing from an unregulated supplier. GHK-Cu sold for research or personal use is not FDA-approved for any therapeutic indication. Anyone considering injectable peptides should be working with a licensed clinician who can monitor copper levels and assess individual risk, not sourcing from a TikTok bio link.

• GHK-Cu has real preclinical evidence for skin repair and anti-inflammatory effects, but human injectable trials are absent.
• The reconstitution math in this video is accurate for a 50mg vial with 3mL bacteriostatic water.
• Continuous year-long use without breaks is not supported by any published safety data in humans.
• Copper toxicity, though uncommon at typical GHK-Cu doses, is a physiological concern that goes unmentioned here.
• Topical GHK-Cu and injectable GHK-Cu are not interchangeable in terms of evidence base.